Brady Cl A saw a welcome improvement to its Relative Strength (RS) Rating on Monday, rising from 69 to 77.
IBD's unique rating measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 in the early stages of their moves. See if Brady Cl A can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Brady Cl A is trying to complete a consolidation with a 77.68 buy point. See if it can clear the breakout price in heavy trade.
The company posted 8% earnings growth in the latest quarterly report. Revenue gains came in at 11%.
The company holds the No. 1 rank among its peers in the Office Supplies Manufacturing industry group. Ennis and Avery Dennison are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
